Clinical Trials Logo

Impulse Control Disorders clinical trials

View clinical trials related to Impulse Control Disorders.

Filter by:

NCT ID: NCT00667212 Completed - Anger Clinical Trials

Psychotherapy for Intermittent Explosive Disorder

Start date: August 2006
Phase: Phase 2
Study type: Interventional

The goal of this study is to examine the effectiveness two forms of psychotherapy (also known as "talk therapy" ) for individuals with anger and aggression problems. Anger and aggression are everywhere - on the road, in the schools, at little league games, at home, and at work. In this study we are testing usefulness of anger management techniques in reducing symptoms of Intermittent Explosive Disorder (IED) and impulsive, aggressive behavior.

NCT ID: NCT00617019 Completed - Parkinson Disease Clinical Trials

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Start date: September 2006
Phase: N/A
Study type: Observational

The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.

NCT ID: NCT00399698 Completed - Bipolar Disorder Clinical Trials

Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.

Start date: May 1999
Phase: Phase 3
Study type: Interventional

This study was developed in order to assess the effects of risperidone (Risperdal) as compared with placebo on cognitive-motor performance (attention, memory, and hand steadiness) and body movements. We propose to study the effects of risperidone on cognitive-motor performance in children already medicated for severe conduct problems. We would also like to look at safety by assessing these children for dyskinetic movements. We already have a sizable cohort of children maintained on risperidone. Our hypotheses are as follows: 1. Risperidone will have no adverse effects on cognitive-motor performance in children who have received maintenance therapy for 4 to 20 months. 2. Children tested during placebo will show no more dyskinetic movements than during risperidone treatment (i.e., there will be no unmasking of tardive dyskinesia).

NCT ID: NCT00282165 Terminated - Psychotic Disorders Clinical Trials

Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order

Start date: November 2006
Phase: Phase 4
Study type: Interventional

In a double blind randomized clinical trial with cross-over design, treatment using naratriptan will be compared to placebo within a group of 30 convicts with psychiatric disorders such as psychosis or psychopathy with repeated aggressive outbursts resistant to conventional psychopharmacologic and other psychotherapeutic treatment. Hypothesis is that addition of naratriptan to the individual treatment regime reduces aggression -and improves general outcome- as compared to addition of placebo and is well tolerated in this group and under these conditions.

NCT ID: NCT00127400 Completed - Anger Clinical Trials

A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED

Start date: February 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see how different forms of "Anger Management" compare in reducing anger and impulsive aggressive symptoms in people. "Anger Management" is a common form of "talk therapy" used to help people with anger problems. There are different types of "talk therapy" used to help people for anger problems and this study will compare two types of talk therapy in people with Intermittent Explosive Disorder (IED). IED is a disorder in which there are frequent and sudden outbursts of anger (yelling, throwing and breaking things, hitting people) that lead to problems with other people socially or at work.

NCT ID: NCT00118014 Completed - Clinical trials for Impulse Control Disorders

Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania

Start date: January 2000
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the extent of symptom remission in patients with trichotillomania following treatment with sertraline and/or behavior therapy.

NCT ID: NCT00115011 Completed - Clinical trials for Impulse Control Disorders

Escitalopram for the Treatment of Self-Injurious Skin Picking

Start date: September 2002
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effectiveness of escitalopram in treating self-injurious skin picking.